Generics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
41
NCT02518529
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
Phase: Phase 2
Role: Collaborator
Start: Feb 28, 2001
Completion: Dec 31, 2002
Loading map...